Shilpa Medicare Limited (SHILPAMED) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.083x

Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.01 Billion ≈ $21.76 Million USD) by net assets (Rs24.39 Billion ≈ $263.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SHILPAMED company net worth for the company's overall valuation and market capitalisation.

Shilpa Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shilpa Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shilpa Medicare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shilpa Medicare Limited ranked by their cash flow conversion efficiency. Explore SHILPAMED operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
EIH Limited
NSE:EIHOTEL
0.054x
CESC Limited
NSE:CESC
0.120x
Mobileye Global Inc. Class A Common Stock
NASDAQ:MBLY
0.016x
Shantui Construction Machinery Co Ltd
SHE:000680
0.056x
Bomin Electronics Co Ltd
SHG:603936
0.009x
Bet Shemesh Engines Holdings 1997 Ltd
TA:BSEN
-0.021x
AMP Limited
F:AMP
-0.012x
MOBVISTA INC. DL-01
F:6MO
N/A

Annual Cash Flow Conversion Efficiency for Shilpa Medicare Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shilpa Medicare Limited from 2006 to 2025. View latest Shilpa Medicare Limited stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs23.64 Billion
≈ $255.63 Million
Rs1.32 Billion
≈ $14.29 Million
0.056x -26.35%
2024-03-31 Rs18.00 Billion
≈ $194.66 Million
Rs1.37 Billion
≈ $14.78 Million
0.076x -40.43%
2023-03-31 Rs17.74 Billion
≈ $191.89 Million
Rs2.26 Billion
≈ $24.46 Million
0.127x +119.59%
2022-03-31 Rs18.11 Billion
≈ $195.87 Million
Rs1.05 Billion
≈ $11.37 Million
0.058x +81.52%
2021-03-31 Rs14.67 Billion
≈ $158.70 Million
Rs469.28 Million
≈ $5.08 Million
0.032x -65.85%
2020-03-31 Rs13.21 Billion
≈ $142.91 Million
Rs1.24 Billion
≈ $13.38 Million
0.094x -24.09%
2019-03-31 Rs11.90 Billion
≈ $128.69 Million
Rs1.47 Billion
≈ $15.87 Million
0.123x +196.51%
2018-03-31 Rs10.80 Billion
≈ $116.78 Million
Rs449.20 Million
≈ $4.86 Million
0.042x +1.43%
2017-03-31 Rs9.14 Billion
≈ $98.83 Million
Rs374.77 Million
≈ $4.05 Million
0.041x -77.31%
2016-03-31 Rs7.12 Billion
≈ $77.01 Million
Rs1.29 Billion
≈ $13.92 Million
0.181x +47.44%
2015-03-31 Rs5.61 Billion
≈ $60.71 Million
Rs688.06 Million
≈ $7.44 Million
0.123x -28.87%
2014-03-31 Rs4.06 Billion
≈ $43.96 Million
Rs700.41 Million
≈ $7.57 Million
0.172x +29.97%
2013-03-31 Rs3.29 Billion
≈ $35.60 Million
Rs436.38 Million
≈ $4.72 Million
0.133x -30.71%
2012-03-31 Rs2.81 Billion
≈ $30.37 Million
Rs537.36 Million
≈ $5.81 Million
0.191x +5.31%
2011-03-31 Rs2.35 Billion
≈ $25.36 Million
Rs426.13 Million
≈ $4.61 Million
0.182x -65.62%
2010-03-31 Rs1.01 Billion
≈ $10.95 Million
Rs535.22 Million
≈ $5.79 Million
0.528x +4.69%
2009-03-31 Rs589.21 Million
≈ $6.37 Million
Rs297.43 Million
≈ $3.22 Million
0.505x +307.88%
2008-03-31 Rs560.02 Million
≈ $6.06 Million
Rs69.31 Million
≈ $749.54K
0.124x -39.79%
2007-03-31 Rs418.09 Million
≈ $4.52 Million
Rs85.93 Million
≈ $929.33K
0.206x +203.23%
2006-03-31 Rs350.17 Million
≈ $3.79 Million
Rs-69.72 Million
≈ $-753.98K
-0.199x --

About Shilpa Medicare Limited

NSE:SHILPAMED India Drug Manufacturers - Specialty & Generic
Market Cap
$2.03 Billion
Rs187.44 Billion INR
Market Cap Rank
#6136 Global
#277 in India
Share Price
Rs958.35
Change (1 day)
+3.26%
52-Week Range
Rs267.00 - Rs964.15
All Time High
Rs985.80
About

Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more